Kevzara 200 MG/1.14 ML pen INJ 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FJL09
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,647
Award facts
- Contract value 100% obligated
- $22,646.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,646.50 delivery order to AmerisourceBergen Drug Corp for the supply of KEVZARA (sarilumab) 200 mg/1.14 mL prefilled pen injections, with an ultimate completion date of August 15, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
KEVZARA is a biologic immunosuppressant used in the treatment of rheumatoid arthritis and other inflammatory conditions. As a prime pharmaceutical distributor serving the Defense Health Agency and military healthcare systems, AmerisourceBergen leverages its extensive supply chain capabilities and competitive positioning to fulfill federal medical procurement requirements. The SPE2DX contract represents a strategic partnership enabling the DLA to source a broad range of pharmaceutical products and medical supplies—including specialty medications, vaccines, and related medical commodities—across multiple therapeutic domains to support military personnel and veterans worldwide.
Quick answers
Who was awarded contract SPE2DB25FJL09?
SPE2DB25FJL09 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FJL09 worth?
The government has obligated $22,647 on SPE2DB25FJL09.
Is contract SPE2DB25FJL09 an order under another contract?
Yes. SPE2DB25FJL09 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJL09 competed?
The extent of competition for SPE2DB25FJL09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award